ROMA (ITALPRESS) – “Law 130, conceived at the beginning of the legislature, had real effects: from the presentation to the Chambers in November 2022 the pilot experiment that ended in May 2025, putting us at the forefront in the world. In the coming years, instead, it will be necessary to continue to endow this law of a financial allocation that allows to anticipate, as much as possible, screening regarding diabetes and celiac disease”. These are the words of the Vice-President of the House, Giorgio Mulè, during the conference this morning on the occasion of the “World Day of Diabetes”. During the panel at the Chamber of Deputies, Mr Mulè added: “The work is still incomplete, we will have to continue working for prevention, involving the professionalism of the sector, especially in order not to leave alone the families of the people affected by these diseases. The uniformity of care requires that the Regions can align themselves, from North to South”.
During the day there was also a message from the Minister of Health, Orazio Schillaci: “I thank all the participants, this is an opportunity for the discussion, for the reflection and to celebrate the results achieved three years by law130, which represents a passage of extraordinary importance. Today the commitment is to follow the current regulatory plan, investing in the prevention and early diagnosis of Type 1 diabetes and celiac disease, introducing a new pediatric screening program. We must continue on this path, with seriousness, determination and responsibility, based on every choice on data and scientific evidence. The goal is to transform the opportunities offered by 130 into concrete results for citizens: behind each given there is a child, who has behind a family with worries and hopes. The challenge that awaits us is to continue the collaboration between institutions, scientific communities, health professionals and associations to achieve effective benefits throughout the national territory.”.
Nicola Zeni, President Fid, said: “The results are promising, since the presence of ketoacidosis in children at the beginning is drastically reduced. Chetoacidosis, in particular, is the real risk linked to the principle of type 1 diabetes, since it can lead to very serious clinical conditions. This is, therefore, the results we are already seeing in this first phase. When my son had the beginning of type 1 diabetes in 2004, for example, we were still limited to punctures and blood glucose testing through the pungidied glucometer. Today, instead, we have sensors, we can have microinfusors and algorithmic systems that help in monitoring. The aim of the Italian Diabetes Foundation, of course, is to arrive at a resolutive cure.”.
Fabiano Marra, president of Diabete Italy, underlined: “We have welcomed this law very enthusiastically, it will be necessary to carry out capillary monitoring on the territory to try to uniform the procedures. The importance of screening is indisputable, to prevent minors from coming to the beginning with a serious condition such as diabetic ketoacidosis. In the regions where the first analyses took place, in fact, the beginnings in ketoacidosis were drastically reduced. The ideal goal would be to reach zero beginnings in ketoacidosis.”.
Also present is Professor Marco Silano, research manager of the Higher Institute of Health; Professor Raffaella Buzzetti; Dr. Antonio D’Avino, national president of FIMP (Italian Federation of Doctors Pediatri) ; Dr. Rossella Valmarana, president of the Italian Association Celiachia; Professor Salvatore De Cosmo, national president of the Medici Diabetologi Association; Dr. Cinzia Grassi of the Edoardo Carta Foundation; Dr. Valentino Cherubini of the Center for Pediatric Diabethology; Dr. Lelio Morviducci, national adviser of Medical Association.
– Photo xv5/Italpress –
(ITALPRESS).
